The next blockbuster indication for @EliLillyandCo drug #tirzepatide could be obstructive #sleepapnea. Topline results from two Phase 3 studies show the drug reduced breathing events from the common #sleepdisorder. medcitynews.com/2024/04/eli-li… $LLY #Zepbound #OSA
1
1
2
417
0
#Obesity is a risk factor for #sleepapnea. The results from the 52-week trials could be associated with weight loss. Along with reducing the number of breathing events per hour, Lilly said results show weight reduction in both trials.
.@EliLillyandCo will present more detailed trial data in June during the scientific sessions meeting of the @AmDiabetesAssn. $LLY also plans mid-2024 regulatory submissions to add #sleepapnea to the #tirzepatide label.